Skip to main content
. 2012 Apr 6;3(3):336–344. doi: 10.18632/oncotarget.475

Figure 4. Kaplan-Meier survival estimates of the overall probability of developing CNS metastasis from the time of the stage IV diagnosis.

Figure 4

In patients stratified based on the amount of p-STAT3 expression, <1% versus ≥1%, in their systemic metastasis, there was no significant difference in time to development of CNS metastasis (p = 0.14; n = 55, 223, respectively).